Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...

New research shows FAM72 family overexpression predicts poorer liver cancer outcomes and introduces a two-gene FAM72 risk ...

A new nanoparticle vaccine successfully prevented several aggressive cancers in mice, including pancreatic and melanoma. The ...

Genomics based research and diagnostic company Strand Life Sciences is planning to give a major push to consumer-centric ...

Philadelphia, PA, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, is pleased to announce the ...

John Quackenbush built a lab that is at the forefront of human genetics research and bioinformatics. Trump administration ...

Dispersing federal research funding, largely concentrated at private universities on the coasts, to the rest of the country ...

The disaster that struck John Quackenbush and his lab at the Harvard T.H. Chan School of Public Health began when the Trump ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

Landmark study explores the whole genomes of 1,364 breast cancers, uncovering predictive biomarkers that link genomic signatures to potential treatment outcomes and support advancing precision ...

LRK-4189, which targets PIP4K2C, a key cancer cell fitness target, is being developed for microsatellite stable (MSS) ...

North America remains the largest contributor to the global exosomes market, driven by substantial R&D investments, expanding clinical trials, and strong collaborations between biotechnology companies ...